Lersivirine
Alternative Names: UK-453,061Latest Information Update: 05 Nov 2023
At a glance
- Originator Pfizer
- Developer Pfizer; ViiV Healthcare
- Class Antiretrovirals; Nitriles; Pyrazoles; Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 14 Feb 2013 Discontinued - Phase-I for HIV infections in Belgium (PO)
- 14 Feb 2013 Discontinued - Phase-I for HIV infections in Singapore (PO)
- 14 Feb 2013 Discontinued - Phase-II for HIV infections in Argentina (PO)